Keith W. Marshall
2017 - Conatus Pharmaceuticals
In 2017, Keith W. Marshall earned a total compensation of $2.6M as Executive Vice President, Chief Operating Officer and Chief Financial Officer at Conatus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $54,592 |
|---|---|
| Option Awards | $2,357,163 |
| Salary | $136,406 |
| Other | $61,489 |
| Total | $2,609,650 |
Marshall received $2.4M in option awards, accounting for 90% of the total pay in 2017.
Marshall also received $54.6K in non-equity incentive plan, $136.4K in salary and $61.5K in other compensation.
Rankings
In 2017, Keith W. Marshall's compensation ranked 4,258th out of 14,666 executives tracked by ExecPay. In other words, Marshall earned more than 71.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,258 out of 14,666 | 71st |
Division Manufacturing | 1,491 out of 5,772 | 74th |
Major group Chemicals And Allied Products | 426 out of 2,075 | 80th |
Industry group Drugs | 327 out of 1,731 | 81st |
Industry Pharmaceutical Preparations | 260 out of 1,333 | 81st |
Source: SEC filing on April 27, 2018.
Marshall's colleagues
We found two more compensation records of executives who worked with Keith W. Marshall at Conatus Pharmaceuticals in 2017.